The World Health Organization has issued a comprehensive new policy brief spotlighting the persistent threat of tuberculosis (TB) among populations at high risk and for people in vulnerable situations. This timely policy brief brings to the fore the disproportionate burden of TB among people who are socially and economically disadvantaged, […]
Purpose of This GuideThe Performance-Based Monitoring and Evaluation Framework (PBMEF) is a key component ofUSAID’s efforts to ensure effective accountability of investments in TB at global, regional, andcountry levels to accelerate progress to end the TB epidemic. The framework streamlines andprioritizes indicators for monitoring progress toward reaching global TB milestones […]
The World Health Organization (WHO) End TB Strategy emphasizes the importance of early tuberculosis (TB) diagnosis and universal access to drug-susceptibility testing (DST). Despite these efforts, significant diagnostic gaps persist globally. In 2022, an estimated 10.6 million people contracted TB, with 7.5 million newly diagnosed cases, but only 4.0 million […]
